Free Trial

Addus HomeCare (ADUS) Competitors

Addus HomeCare logo
$112.64 -5.36 (-4.54%)
Closing price 03:59 PM Eastern
Extended Trading
$112.74 +0.10 (+0.09%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ADUS vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, PRVA, CON, LFST, and VCYT

Should you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

Addus HomeCare vs.

Addus HomeCare (NASDAQ:ADUS) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, community ranking, media sentiment, valuation, profitability and risk.

Addus HomeCare has a net margin of 6.50% compared to Guardant Health's net margin of -59.05%. Addus HomeCare's return on equity of 9.62% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare6.50% 9.62% 7.37%
Guardant Health -59.05%-19,157.20%-25.96%

Addus HomeCare currently has a consensus price target of $142.57, suggesting a potential upside of 20.82%. Guardant Health has a consensus price target of $53.29, suggesting a potential upside of 6.38%. Given Addus HomeCare's stronger consensus rating and higher probable upside, analysts plainly believe Addus HomeCare is more favorable than Guardant Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.25
Guardant Health
0 Sell rating(s)
0 Hold rating(s)
20 Buy rating(s)
1 Strong Buy rating(s)
3.05

Addus HomeCare has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500.

Addus HomeCare received 28 more outperform votes than Guardant Health when rated by MarketBeat users. However, 71.76% of users gave Guardant Health an outperform vote while only 69.09% of users gave Addus HomeCare an outperform vote.

CompanyUnderperformOutperform
Addus HomeCareOutperform Votes
333
69.09%
Underperform Votes
149
30.91%
Guardant HealthOutperform Votes
305
71.76%
Underperform Votes
120
28.24%

In the previous week, Guardant Health had 12 more articles in the media than Addus HomeCare. MarketBeat recorded 19 mentions for Guardant Health and 7 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.13 beat Guardant Health's score of 0.57 indicating that Addus HomeCare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Addus HomeCare
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Guardant Health
8 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

95.3% of Addus HomeCare shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 4.6% of Addus HomeCare shares are owned by company insiders. Comparatively, 6.1% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Addus HomeCare has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$1.21B1.79$62.52M$4.4326.64
Guardant Health$774.00M8.02-$479.45M-$3.39-14.78

Summary

Addus HomeCare beats Guardant Health on 13 of the 19 factors compared between the two stocks.

Get Addus HomeCare News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADUS vs. The Competition

MetricAddus HomeCareHome health care services IndustryMedical SectorNASDAQ Exchange
Market Cap$2.13B$3.15B$5.60B$8.65B
Dividend YieldN/A0.36%5.27%4.19%
P/E Ratio26.5229.9327.3320.13
Price / Sales1.761.13412.21156.99
Price / Cash21.6517.2938.2534.64
Price / Book2.663.577.154.74
Net Income$62.52M-$57.02M$3.23B$247.88M
7 Day Performance3.54%-0.04%3.49%2.64%
1 Month Performance4.56%0.66%12.92%9.95%
1 Year Performance-1.74%28.34%32.15%15.33%

Addus HomeCare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADUS
Addus HomeCare
4.7903 of 5 stars
$112.64
-4.5%
$142.57
+26.6%
+1.0%$2.07B$1.21B25.7833,200Positive News
Analyst Forecast
Analyst Revision
GH
Guardant Health
3.3316 of 5 stars
$49.53
+3.1%
$53.29
+7.6%
+66.6%$6.14B$774.00M-13.911,790Insider Trade
OPCH
Option Care Health
4.1511 of 5 stars
$31.67
-0.7%
$35.50
+12.1%
+11.9%$5.19B$5.19B26.615,600Positive News
RDNT
RadNet
3.5177 of 5 stars
$59.07
+0.7%
$69.75
+18.1%
-3.6%$4.43B$1.87B-843.748,970Positive News
BTSG
BrightSpring Health Services
0.6942 of 5 stars
$23.86
-1.0%
$23.56
-1.3%
+98.4%$4.16B$11.86B-91.7735,000News Coverage
Positive News
SHC
Sotera Health
2.568 of 5 stars
$12.36
+0.5%
$15.80
+27.8%
+3.0%$3.51B$1.11B49.443,000Positive News
High Trading Volume
SGRY
Surgery Partners
2.7324 of 5 stars
$23.36
+0.7%
$33.56
+43.6%
-9.2%$2.99B$3.17B-48.6712,200Positive News
PRVA
Privia Health Group
3.4174 of 5 stars
$23.24
+0.2%
$27.77
+19.5%
+35.7%$2.83B$1.80B232.42810
CON
Concentra Group Holdings Parent
N/A$22.09
+0.3%
$28.50
+29.0%
N/A$2.81B$1.93B16.4911,000Positive News
LFST
LifeStance Health Group
2.0836 of 5 stars
$5.88
+0.7%
$8.50
+44.6%
+6.9%$2.29B$1.28B-22.626,640
VCYT
Veracyte
4.2141 of 5 stars
$27.85
+1.4%
$40.90
+46.9%
+33.5%$2.18B$463.39M-185.67790

Related Companies and Tools


This page (NASDAQ:ADUS) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners